REPL News

Latest breaking news and updates for REPL stock.

Track all markets on TradingView

Class Action Announcement for Replimune Group, Inc. (REPL): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Replimune Group, Inc.

RADNOR, Pa., Aug. 15, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replimun...

How might the lawsuit affect the volatility and trading volume of REPL shares in the coming weeks? What is the potential impact on Replimune's competitive positioning and partnership agreements within the oncology immunotherapy space? Could the class action lead to a material adverse change (MAC) clause being triggered in any of Replimune's existing financing agreements?
Lawsuits
14 days ago
Read more prnewswire

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities laws...

How does the market’s reaction to this lawsuit compare to reactions to similar legal disclosures by peer companies in the oncology/biotech space? Are there any insider trading activities or unusual options activity surrounding the announcement that could signal market expectations? Will the lawsuit affect the company’s ability to raise capital through equity or debt offerings in the near future?
Lawsuits
14 days ago
Read more prnewswire

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm

NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 an...

What is the expected timeline for resolution of the case and how should that influence trading strategies? How does the market’s reaction to this lawsuit compare to reactions to similar cases in the sector? Could the lawsuit trigger a review of REPL's recent disclosures or financial statements by regulators?
Lawsuits
15 days ago
Read more prnewswire

NASDAQ: REPL: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Replimune Group, Inc.

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replim...

How should position sizing and stop‑loss levels be adjusted in response to this development? Might this litigation lead to a material adverse change (MAC) clause activation in any of REPL's existing contracts? Are there any disclosed details about the alleged securities violations that could affect REPL's business outlook?
Lawsuits
16 days ago
Read more businesswire

REPL Stock News: Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Replimune Group, Inc. Class Action Lawsuit

SAN DIEGO, Aug. 12, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (NASDAQ: REP...

What is the anticipated effect on REPL’s short‑interest and potential for a short‑squeeze scenario? How is the market’s sentiment toward REPL shifting in response to the negative sentiment score of -70? Could the lawsuit lead to a material change in REPL’s business strategy, partnerships, or pipeline timelines?
Lawsuits
17 days ago
Read more prnewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. ("Replimune" or the "Company")(NASDAQ: REPL). Such investors...

How should I adjust my risk management or position sizing for REPL given this development? Are there any insider trades or notable positions being taken in response to the news? What is the expected impact on the stock's volatility and implied volatility in options markets?
Legal
18 days ago
Read more prnewswire

Class Action Filed Against Replimune Group, Inc. (REPL) - September 22, 2025 Deadline to Join - Contact The Gross Law Firm

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). Shareholders who purchased shares of REPL during the ...

What steps should investors take to manage risk exposure to REPL in light of this development? How does the legal exposure compare to that of competitors in the biotech sector? Could the class action lead to a material adverse change (MAC) event that might trigger a breach of loan covenants or affect credit facilities?
Lawsuits
18 days ago
Read more prnewswire

Shareholders who lost money on Replimune Group, Inc. (NASDAQ: REPL) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 22nd

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased ...

What are the potential long‑term implications for REPL's business fundamentals and pipeline if the lawsuit proceeds? Could the lawsuit trigger a credit rating downgrade or affect REPL's ability to raise capital? How should I adjust my risk management and position sizing for REPL in light of this development?
Lawsuits
18 days ago
Read more prnewswire

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law Firm

NEW YORK, Aug. 9, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and...

How does this legal development compare to recent securities lawsuits faced by other companies in the oncology/biotech sector? Could the lawsuit affect REPL's ability to raise capital, conduct follow‑on offerings, or secure strategic partnerships? What are the possible scenarios for settlement or dismissal, and how should each be factored into risk management strategies?
Lawsuits
20 days ago
Read more prnewswire

Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Replimune To Contact Him Directly To Discuss Their Options If you purchased or acq...

What timeline should traders consider for the lawsuit's resolution and its impact on the stock? How could the lawsuit influence analyst coverage and earnings forecasts for REPL? What are the potential implications for REPL's partnerships and collaborations?
Lawsuits
20 days ago
Read more prnewswire